Portal hypertension

Clinics in Liver Disease

Volumn 5, Issue 2, 2001, Pages 509-540

  Garcia Jr, Nelson ^b   Sanyal, Arun J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; ISOSORBIDE MONONITRATE; LOSARTAN; NITRATE; OCTREOTIDE; PROPRANOLOL; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; TERLIPRESSIN;

CLINICAL TRIAL; DRUG EFFICACY; ESOPHAGUS HEMORRHAGE; ESOPHAGUS VARICES BLEEDING; HUMAN; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; REVIEW; TREATMENT FAILURE;

EID: 0035016515     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1089-3261(05)70176-8     Document Type: Review

References (119)

1. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices [see comments] N Engl J Med 319 1988 983 989
2. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, single-blind, multicenter clinical trial. The Veterans Affairs Cooperative Variceal Sclerotherapy Group [see comments] N Engl J Med 324 1991 1779 1784
3. T.I. Al F.S. Fachartz A. Al Jumah Randomized trial of ligation versus combined ligation and sclerotherapy for bleeding esophageal varices [see comment] Gastrointest Endosc 50 1999 1 6
4. P.T. Alexandrino M.M. Alves C.J. Pinto Propranolol or endoscopic sclerotherapy in the prevention of recurrence of variceal bleeding. A prospective, randomized controlled trial J Hepatol 7 1988 175 185
5. D. Alvarez M. de las Heras R. Abecasis Daily variation in portal blood flow and the effect of propranolol administration in a randomized study of patients with cirrhosis Hepatology 25 1997 548 550
6. D. Alvarez D. Golombek P. Lopez Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis Hepatology 20 1994 1198 1203
7. D. Alvarez C. Miguez A. Podesta Postprandial vascular response in patients with cirrhosis. Short-term effects of propranolol administration Dig Dis Sci 39 1994 1288 1293
8. T. Andreani R.E. Poupon G.B.J. Balkau Efficacite comparee du propranolol et de sclerose endoscopique de varices oesophaienned dans la prevention des recidives d'hemorragies digestives au cours des cirrhosis Etude controlee. Gastroenterol Clin Biol 15 suppl 1991 A215
9. M. Angelico L. Carli C. Piat Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis Gastroenterology 113 1997 1632 1639
10. M. Angelico L. Carli C. Piat Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis Gastroenterology 104 1993 1460 1465
11. J. Argonz D. Kravetz A. Suarez Variceal band ligation and variceal band ligation plus sclerotherapy in the prevention of recurrent variceal bleeding in cirrhotic patients: A randomized, prospective and controlled trial Gastrointest Endosc 51 2000 157 163
12. R. Banares E. Moitinho B. Piqueras Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis Hepatology 30 1999 79 83
13. J.C. Bandi J.C. Garcia-Pagan A. Escorsell Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis Hepatology 28 1998 677 682
14. M.S. Barsoum F.I. Bolous A.A. El Rooby Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices Br J Surg 69 1982 76 78
15. M.S. Barsoum F.I. Bolous A.A. El Rooby Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices Br J Surg 69 1982 76 78
16. F. Bendtsen J.H. Henriksen T.I. Sorensen Long-term effects of oral propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis and oesophageal varices Scand J Gastroenterol 26 1991 933 939
17. K. Beppu K. Inokuchi N. Koyanagi Prediction of variceal hemorrhage by esophageal endoscopy Gastrointest Endosc 27 1981 213 218
18. B. Bernard D. Lebrec P. Mathurin Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis Hepatology 25 1997 63 70
19. I. Besson P. Ingrand B. Person Sclerotherapy with or without octreotide for acute variceal bleeding N Engl J Med 333 1995 555 560
20. J. Bosch R. Masti D. Kravetz Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis Hepatology 4 1984 1200 1205
21. A.K. Burroughs G. Hamilton A. Phillips A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices N Engl J Med 321 1989 857 862
22. A.K. Burroughs D. Patch Primary prevention of bleeding from esophageal varices [editorial; comment] N Engl J Med 340 1999 1033 1035
23. P. Cales Factors associated with failure of propranolol for the prevention of first bleeding in cirrhotic patients. The Study Group of Primary Prophylaxis Gastroenterol Clin Biol 16 1992 504 510
24. P. Cales H. Desmorat J.P. Vinel Incidence of large oesophageal varices in patients with cirrhosis: Application to prophylaxis of first bleeding Gut 31 1990 1298 1302
25. P. Cales F. Oberti J.L. Payen Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: A randomized trial. French-Speaking Club for the Study of Portal Hypertension Eur J Gastroenterol Hepatol 11 1999 741 745
26. J.P. Cello J.H. Grendell R.A. Crass Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage N Engl J Med 311 1984 1589 1594
27. T.T. Chang F.Y. Lee Y.T. Tsai A randomized controlled study of low-dose and high-dose terlipressin in the control of acute oesophageal variceal haemorrhage J Gastroenterol Hepatol 6 1991 481 484
28. T.N. Chau D. Patch Y.W. Chan “Salvage” transjugular intrahepatic portosystemic shunts: Gastric fundal compared with esophageal variceal bleeding [see comments] Gastroenterology 114 1998 981 987
29. E. Colombo M.A. Casiraghi G. Minoli First bleeding episode from oesophageal varices in cirrhotic patients: A prospective study of endoscopic predictive factors Italian Journal of Gastroenterology 27 1995 345 348
30. G. D'Amico A. Luca Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding Baillieres Clin Gastroenterol 11 1997 243 256
31. G. D'Amico L. Pagliaro J. Bosch The treatment of portal hypertension: A meta-analytic review Hepatology 22 1995 332 354
32. G. D'Amico M. Traina G. Vizzini Terlipressin or vasopressin plus transdermal nitroglycerin in a treatment strategy for digestive bleeding in cirrhosis. A randomized clinical trial. Liver Study Group of V. Cervello Hospital J Hepatol 20 1994 206 212
33. J. de la Pena M. Rivero E. Sanchez Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: Prospective randomized trial Gastrointest Endosc 49 1999 417 423
34. J.M. Dollet B. Champigneulle A. Patris [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study] Gastroenterol Clin Biol 12 1988 234 239
35. A. Escorsell J.M. Bordas B. Castaneda Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension Hepatology 31 2000 1061 1067
36. J.M. Fardy A. Laupacis A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices Am J Gastroenterol 89 1994 1938 1948
37. F. Feu J.C. Garcia-Pagan J. Bosch Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis [see comments] Lancet 346 1995 1056 1059
38. E. Fort D. Sautereau C. Silvain A randomized trial of terlipressin plus nitroglycerin vs. balloon tamponade in the control of acute variceal hemorrhage Hepatology 11 1990 678 681
39. J.G. Freeman I. Cobden A.H. Lishman Controlled trial of terlipressin (“Glypressin”) versus vasopressin in the early treatment of oesophageal varices Lancet 2 1982 66 68
40. D. Garcia-Compean P. Blanc J.M. Bories Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis: A randomized controlled trial Arch Med Res 28 1997 241 245
41. J.C. Garcia-Pagan M. Navasa J. Bosch Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis Hepatology 11 1990 230 238
42. J.C. Garcia-Pagan C. Santos J.A. Barbera Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension Gastroenterology 111 1996 1300 1306
43. G. Garcia-Tsao R.J. Groszmann R.L. Fisher Portal pressure, presence of gastroesophageal varices and variceal bleeding Hepatology 5 1985 419 424
44. N. Garcia Jr Z. Jarai F. Mirshahi The systemic and portal effects of anandamide Am J Gastrointest Liver Physiol 280 2001 614 620
45. P.K. Garg Y.K. Joshi R.K. Tandon Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: A prospective randomized study Gastrointest Endosc 50 1999 369 373
46. A.E. Gimson D. Westaby J. Hegarty A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage Hepatology 6 1986 410 413
47. J. Goulis D. Patch A.K. Burroughs Bacterial infection in the pathogenesis of variceal bleeding [see comments] Lancet 353 1999 139 142
48. N.D. Grace Prevention of initial variceal hemorrhage Gastroenterol Clin North Am 21 1992 149 161
49. N.D. Grace Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. American College of Gastroenterology Practice Parameters Committee Am J Gastroenterol 92 1997 1081 1091
50. D.Y. Graham J.L. Smith The course of patients after variceal hemorrhage Gastroenterology 80 1981 800 809
51. I.M. Gralnek D.M. Jensen T.O.G. Kovacs The economic impact of esophageal variceal hemorrhage: Cost-effectiveness implications of endoscopic therapy Hepatology 29 1999 44 50
52. J.M. Henderson M.H. Kutner W.J. Millikan Jr Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial [see comments] Ann Intern Med 112 1990 262 269
53. C.N. Housset D.C. Rockey S.L. Friedman Hepatic lipocytes: A major target for endothelin-1 J Hepatol 22 1995 55 60
54. Y.H. Huang H.Z. Yeh G.H. Chen Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: Long-term efficacy and safety Gastrointest Endosc 52 2000 160 167
55. S.J. Hwang H.C. Lin C.F. Chang A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding J Hepatol 16 1992 320 325
56. O. Ink T. Martin T. Poynard Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial Hepatology 16 1992 912 919
57. R. Jalan P.C. Hayes UK guidelines on the management of variceal haemorrhage in cirrhotic patients British Society of Gastroenterology. Gut 46 suppl 3–4 2000 III1 III15
58. L.S. Jensen N. Krarup Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy Scand J Gastroenterol 24 1989 339 345
59. S. Kitano N. Koyanagi Y. Iso Prevention of recurrence of esophageal varices after endoscopic injection sclerotherapy with ethanolamine oleate Hepatology 7 1987 810 815
60. D. Kravetz J. Bosch M. Arderiu Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: Influence of the extent of portal-systemic shunting Hepatology 9 1989 808 814
61. D. Kravetz E. Sikuler R.J. Groszmann Splanchnic and systemic hemodynamics in portal hypertensive rats during hemorrhage and blood volume restitution Gastroenterology 90 1986 1232 1240
62. R.J. Kroeger R.J. Groszmann Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model Hepatology 5 1985 97 101
63. J.M. LaBerge E.J. Ring J.R. Lake Transjugular intrahepatic portosystemic shunts: Preliminary results in 25 patients J Vasc Surg 16 1992 258 267
64. L. Laine H.M. El Newihi B. Migikovsky Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices Ann Intern Med 119 1993 1 7
65. A.W. Larson H. Cohen B. Zweiban Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial JAMA 255 1986 497 500
66. D. Lebrec P. Hillon C. Munoz The effect of propranolol on portal hypertension in patients with cirrhosis: A hemodynamic study Hepatology 2 1982 523 527
67. Y.T. Lee J.J. Sung M.Y. Yung Use of color Doppler EUS in assessing azygos blood flow for patients with portal hypertension Gastrointest Endosc 50 1999 47 52
68. V.K. Leung J.J. Sung A.T. Ahuja Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding Gastroenterology 112 1997 1811 1816
69. G.H. Lo K.H. Lai J.S. Cheng Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy Gastrointest Endosc 49 1999 428 436
70. V.A. Luketic A.J. Sanyal Esophageal varices: Clinical presentation, medical therapy, and endoscopic therapy Gastroenterol Clin North Am 29 2000 337 385
71. C. Merkel R. Marin E. Enzo Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP) [see comments] Lancet 348 1996 1677 1681
72. C. Merkel R. Marin D. Sacerdoti Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis Hepatology 31 2000 324 329
73. L.S. Miller T.D. Schiano A. Adrain Comparison of high-resolution endoluminal sonography to video endoscopy in the detection and evaluation of esophageal varices Hepatology 24 1996 552 555
74. S. Moncada A. Higgs The L-arginine-nitric oxide pathway N Engl J Med 329 1993 2002 2012
75. R. Moreau D. Roulot A. Braillon Low dose of nitroglycerin failed to improve splanchnic hemodynamics in patients with cirrhosis: Evidence for an impaired cardiopulmonary baroreflex function Hepatology 10 1989 93 97
76. F. Nevens R. Bustami I. Scheys Variceal pressure is a factor predicting the risk of a frst variceal bleeding: A prospective cohort study in cirrhotic patients Hepatology 27 1998 15 19
77. Y. Nishikawa Y. Hosokawa T. Doi Evaluation of endoscopic injection sclerotherapy with and without simultaneous ligation for the treatment of esophageal varices [see comments] J Gastroenterol 34 1999 159 162
78. M.J. Orloff M.S. Orloff S.L. Orloff Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver [see comments] J Am Coll Surg 180 1995 257 272
79. K.J. Paquet J.F. Kalk C.P. Klein Prophylactic sclerotherapy for esophageal varices in high-risk cirrhotic patients selected by endoscopic and hemodynamic criteria: A randomized, single-center controlled trial [see comments] Endoscopy 26 1994 734 740
80. J.P. Pascal P. Cales Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices [published erratum appears in N Engl J Med 318:994, 1998] N Engl J Med 317 1987 856 861
81. T. Poynard P. Cales L. Pasta Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group N Engl J Med 324 1991 1532 1538
82. T. Poynard D. Lebrec P. Hillon Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: A prospective study of factors associated with rebleeding Hepatology 7 1987 447 451
83. D. Prandi B. Rueff J. Roche-Sicot Life-threatening hemorrhage of the digestive tract in cirrhotic patients. An assessment of the postoperative mortality after emergency portacaval shunt Am J Surg 131 1976 204 209
84. H.L. Price L.H. Cooperman J.C. Warden Control of the splanchnic circulation in man. Role of beta-adrenergic receptors Circ Res 21 1967 333 340
85. M. Primignani B. Andreoni L. Carpinelli Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial. New Italian Endoscopic Club Hepatology 21 1995 1322 1327
86. W.G. Rector Jr K.F. Hossack J.B. Ready Nitroglycerin for portal hypertension: A controlled comparison of the hemodynamic effects of graded doses J Hepatol 10 1990 375 380
87. O. Riggio M. Merlli G. Pedretti Hepatic encephalopathy after transjugular intrahepatic portosystem shunt. Incidence and risk factors Dig Dis Sci 41 1996 578 584
88. G.P. Rigo A. Merighi N.J. Chahin A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices Gastrointest Endosc 38 1992 425 429
89. E.J. Ring J.R. Lake J.P. Roberts Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation Ann Intern Med 116 1992 304 309
90. J.Y. Robert J.L. Raoul J.F. Bretagne Unusual presentation of a case of brain abscess after endoscopic injection sclerotherapy of esophageal varices Endoscopy 23 1991 237 238
91. D. Rockey The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin, and nitric oxide Hepatology 25 1997 2 5
92. D.C. Rockey J.J. Chung Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension Gastroenterology 114 1998 344 351
93. F. Rodriguez-Perez R.J. Groszmann Pharmacologic treatment of portal hypertension Gastroenterol Clin North Am 21 1992 15 40
94. M. Rossle K. Haag A. Ochs The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding N Engl J Med 330 1994 165 171
95. B.A. Runyon Management of adult patients with ascites caused by cirrhosis Hepatology 27 1998 264 272
96. Z.A. Saeed G.V. Stiegmann F.C. Ramirez Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: A multicenter prospective randomized trial Hepatology 25 1997 71 74
97. R.A. Sanowski C.M. Brayko R.A. Kozarek Endoscopic injection sclerotherapy of esophageal varices Gastrointest Endosc 29 1983 242 243
98. A.J. Sanyal The value of EUS in the management of portal hypertension Gastrointest Endosc 52 2000 1 3
99. A.J. Sanyal A.M. Freedman V.A. Luketic Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy Gastroenterology 111 1996 138 146
100. A.J. Sanyal A.M. Freedman V.A. Luketic Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial Ann Intern Med 126 1997 849 857
101. A.J. Sanyal A.M. Freedman V.A. Luketic The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts Gastroenterology 112 1997 889 898
102. A.J. Sanyal A.M. Freedman M.L. Shiffman Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study Hepatology 20 1994 46 55
103. S.K. Sarin R.J. Groszmann P.G. Mosca Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension J Clin Invest 87 1991 1032 1036
104. S.K. Sarin A. Kumar Sclerosants for variceal sclerotherapy: A critical appraisal Am J Gastroenterol 85 1990 641 649
105. S.K. Sarin G.S. Lamba M. Kumar Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding N Engl J Med 340 1999 988 993
106. T.D. Schiano A.L. Adrain M.J. Cassidy Use of high-resolution endoluminal sonography to measure the radius and wall thickness of esophageal varices Gastrointest Endosc 44 1996 425 428
107. A.W. Schneider J.F. Kalk C.P. Klein Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis Hepatology 29 1999 334 339
108. B.M. Schuman J.W. Beckman F.J. Tedesco Complications of endoscopic injection sclerotherapy: A review Am J Gastroenterol 82 1987 823 830
109. H.M. Shahi S.K. Sarin Prevention of first variceal bleed: An appraisal of current therapies Am J Gastroenterol 93 1998 2348 2358
110. C.S. Shim J.Y. Cho Y.J. Park Mini-detachable snare ligation for the treatment of esophageal varices Gastrointest Endosc 50 1999 673 676
111. M.R. Silveira Rohr E.S. Siqueira C.Q. Brant Prospective study of bacteremia rate after elastic band ligation and sclerotherapy of esophageal varices in patients with hepatosplenic schistosomiasis Gastrointest Endosc 46 1997 321 323
112. C. Soderlund I. Magnusson S. Torngren Terlipressin (triglycyl-lysine vasopressin) controls acute bleeding oesophageal varices. A double-blind, randomized, placebo-controlled trial Scand J Gastroenterol 25 1990 622 630
113. A.J. Stanley E.H. Forrest H.F. Lui Band ligation versus propranolol or isosorbide mononitrate in the primary prophylaxis of variceal haemorrage: Preliminary results of a randomised controlled trial Gut 42 suppl 1 1998 A19
114. J.J. Sung S.C. Chung M.Y. Yung Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation Lancet 346 1995 1666 1669
115. D.R. Triger A.G. Johnson J.E. Brazier A prospective trial of endoscopic sclerotherapy voesophageal transection and gastric devascularisation in the long term management of bleeding oesophageal varices Gut 33 1992 1553 1558
116. L. Vargas L. Ovalle R. Estay [Esophagogastric varix hemorrhage. Experience with cyanoacrylate and polidocanol in 68 patients with active hemorrhage] Rev Med Chil 127 1999 685 692
117. C. Villanueva J. Balanzo M.T. Novella Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding N Engl J Med 334 1996 1624 1629
118. S. Walker H.P. Kreichgauer J.C. Bode Terlipressin vs. somatostatin in bleeding esophageal varices: A controlled, double-blind study Hepatology 15 1992 1023 1030
119. B.F. Zuberi Q. Baloch Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis Am J Gastroenterol 95 3 2000 768 771